Preferred Label : Asparaginase Erwinia chrysanthemi;

NCIt synonyms : Asparaginase-Erwinia; Crisantaspasum; Crisantaspase; RC-P JZP-458; Recombinant Erwinia asparaginase JZP-458; Asparaginase Erwinia Chrysanthemi (Recombinant)-rywn; Recombinant Crisantaspase JZP-458; Recombinant Asparaginase erwinia chrysanthemi JZP-458; Crisantaspase Biobetter JZP-458;

NCIt related terms : Rylaze; Asparaginase erwinia chrysanthemi-rywn;

NCIt definition : A recombinant form of asparaginase derived from the bacterium Erwinia chrysanthemi, genetically engineered to be produced in Pseudomonas fluorescens, with potential antineoplastic activity. Upon administration, asparaginase Erwinia chrysanthemi hydrolyzes L-asparagine to L-aspartic acid and ammonia. This depletes cancer cells of asparagine, which blocks protein synthesis and tumor cell proliferation. Asparagine is critical to protein synthesis in cancer cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. Asparaginase Erwinia chrysanthemi can be used as an alternative in patients who are hypersensitive to Escherichia (E.) coli-derived asparaginase products.;

UNII : D733ET3F9O;

CAS number : 9015-68-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 9015-68-3 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Erwinase; Erwinaze; Rylaze;

Molecule name : JZP-458; JZP 458; PF743;

NSC code : 106977;

Codes from synonyms : 27223; 46;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/enrylaze
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Asparaginase Erwinia chrysanthemi
Asparaginase Erwinia chrysanthemi
asparaginase

---
https://www.ansm.sante.fr/actualites/leucemie-aigue-lymphoblastique-double-circuit-de-commande-de-crisantaspase-erwinase
2021
false
false
false
France
French
drug information
medication systems, hospital
Asparaginase Erwinia chrysanthemi
asparaginase
france
asparaginase
Acute Lymphoblastic Leukemia

---
http://www.has-sante.fr/portail/jcms/c_2566486/fr/erwinase
http://www.has-sante.fr/portail/jcms/c_2566486/fr/erwinase-l-asparaginase-issue-d-erwinia-antineoplasique
2015
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
asparaginase
asparaginase
antineoplastic agents
Asparaginase Erwinia chrysanthemi
antineoplastic combined chemotherapy protocols
Acute Lymphoblastic Leukemia
injections, intravenous
injections, intramuscular
child
drug hypersensitivity
adolescent
asparaginase
guidelines for drug use
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)
precursor cell lymphoblastic Leukemia-Lymphoma

---
Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.